Thiotepa fegestrin side effects commonly include gastrointestinal symptoms and musculoskeletal reactions, which vary in duration depending on individual tolerance and dosage used.
Thiotepa fegestatin is a polyethylene glycol recombinant human granulocyte stimulating factor, the mechanism of action is to bind to the surface receptor of hematopoietic cells, and then stimulate the proliferation of granulocyte system, differentiation and maturation, and activation of granulocyte function. It is used for the prevention and treatment of absolute neutrophil count (ANC) reduction after tumor chemotherapy.
With thiotepa fegestatin, common adverse events include gastrointestinal symptoms (vomiting, nausea, poor appetite) and musculoskeletal reactions (transient bone pain, muscle pain). There are no clinical studies that count the duration of the various side effects.
It should be noted that in pregnant women, there are no adequate data from controlled studies on the safety of thiotepa fexofilgrastim. It should also be used with caution in nursing women. In addition, there are no efficacy or safety data on the treatment of pediatric patients.
If you need to use thiotepa fegestrin, it is recommended that you do so under the supervision of a doctor. If there is any abnormality, you should immediately seek medical attention or inform the attending physician and take therapeutic measures as prescribed by the doctor to avoid delay.